Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3815 publications
In insulin-naive T2D, fixed-dose weekly efsitora was noninferior to daily glargine for reducing HbA1c at 52 wk.
Journal: Annals of internal medicine
Published: October 06, 2025
Cost-effectiveness of insulin icodec for the treatment of type 2 diabetes in Canada.
Journal: Journal of medical economics
Published: August 25, 2025
Retrospective Evaluation of Early Glargine Administration in Adults With Diabetic Ketoacidosis.
Journal: Cureus
Published: August 17, 2025
Correction to "Effects of Insulin Glargine U300 Versus Insulin Degludec U100 on Glycemic Variability, Hypoglycemia, and Diet Evaluated by Continuous Glucose Monitoring in Type 1 Diabetes: A Retrospective Cross-Sectional Study".
Journal: The Kaohsiung journal of medical sciences
Published: August 13, 2025
Efficacy and Safety of Once-Weekly Insulin Icodec in Indian Participants with Diabetes: Results from ONWARDS 1, 4, and 6 Studies.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: August 08, 2025
Survival following intentional overdose of veterinary insulin: A case report.
Journal: Toxicology reports
Published: August 04, 2025
Efficiency of Gla-300 versus Gla-100 Across Age Groups in People Living with Type 2 Diabetes in France: A Post Hoc Analysis of an Observational Longitudinal Study.
Journal: Advances in therapy
Published: July 29, 2025
Comparable glycemic outcomes with insulin glargine and insulin degludec during exercise in adolescents with type 1 diabetes using a standardized management protocol.
Journal: Diabetes, obesity & metabolism
Published: July 28, 2025
Thrice-Weekly Insulin Degludec Versus Once-Daily Insulin Glargine in Insulin-Naïve Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis.
Journal: British journal of hospital medicine (London, England : 2005)
Published: July 24, 2025
Correction to: Safety and Effectiveness of Glargine 300 U/ml After Switching from Basal Insulins in Patients with Type 1 Diabetes: COMET-T Study.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: July 14, 2025
Efficacy and safety of iGlarLixi versus IDegAsp by baseline β-cell function in Chinese people with type 2 diabetes: Exploratory analyses of the Soli-D study.
Journal: Diabetes, obesity & metabolism
Published: July 02, 2025
Emerging perspectives on once-weekly insulins in type 1 and type 2 diabetes: a mini-review.
Journal: Frontiers in endocrinology
Published: June 30, 2025
Last Updated: 10/31/2025